Pages that link to "Q78174884"

The following pages link to Treatment of alcohol withdrawal syndrome with gabapentin (Q78174884):

Displaying 27 items.

• Glutamatergic substrates of drug addiction and alcoholism (Q24648924) (← links)
• Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation (Q26853630) (← links)
• Gabapentin misuse, abuse and diversion: a systematic review (Q30249803) (← links)
• Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function (Q30438149) (← links)
• Update on the neurobiology of alcohol withdrawal seizures (Q34213603) (← links)
• Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients (Q34258101) (← links)
• Alcohol withdrawal kindling: is there a role for anticonvulsants? (Q34396593) (← links)
• Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders (Q34472695) (← links)
• Update: new uses for lithium and anticonvulsants (Q34710521) (← links)
• Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide (Q34781413) (← links)
• Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence (Q35195048) (← links)
• Gabapentin Combined With Naltrexone for the Treatment of Alcohol Dependence (Q35482135) (← links)
• Recent advances in the pharmacotherapy of alcoholism (Q35882076) (← links)
• Gabapentin Therapy in Psychiatric Disorders: A Systematic Review (Q36518678) (← links)
• Cellular and behavioral interactions of gabapentin with alcohol dependence (Q36805266) (← links)
• Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. (Q36875830) (← links)
• Glutamatergic medications for the treatment of drug and behavioral addictions (Q37871133) (← links)
• Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date (Q38185313) (← links)
• Psychiatric Uses of Newer Anticonvulsants (Q39853694) (← links)
• Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. (Q42655671) (← links)
• Treatment of alcohol withdrawal with gabapentin (Q45711962) (← links)
• A Qualitative Analysis of Gabapentin Misuse and Diversion Among People Who Use Drugs in Appalachian Kentucky (Q47654027) (← links)
• Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat. (Q51855387) (← links)
• Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol. (Q55355846) (← links)
• Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial (Q90158223) (← links)
• Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital (Q92284835) (← links)
• Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta-analysis (Q97540059) (← links)